Prophylactic Pancreatic Duct Stenting in Acute Necrotizing Pancreatitis — ERPNEC  

Acute Necrotizing Pancreatitis Clinical Trial

Official title: Prophylactic Pancreatic Duct Stenting in Acute Necrotizing Pancreatitis: a Prospective Randomized Controlled Multicenter Study

Status Recruiting

Clinical Trial Summary

Since the majority of patients with necrotizing pancreatitis will experience a leak from the pancreatic duct during their course of disease resulting in intra- and peripancreatic fluid collections, it is reasonable to hypothesize that placement of a ductal stent may prevent some of the late complications and morbidity associated with pancreatic necrosis. This prospective, randomized, controlled multicenter trial investigates the role of early prophylactic ductal stenting in acute necrotizing pancreatitis.

The purpose of the study is to determinate the safety and feasibility of early prophylactic pancreatic duct stenting in necrotizing pancreatitis in reducing complications, length of stay in hospital and in in-tensive care unit compared to the traditional treatment.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Acute Necrotizing Pancreatitis
• Pancreatitis
• Pancreatitis, Acute Necrotizing

• NCT number: NCT01767233
• Study type: Interventional
• Source: University of Oulu
• Contact: Heikki K Karjula, MD
• Phone: + 358 08 3152830
• Email: heikki.karjula@ppshp.fi
• Status: Recruiting
• Phase: N/A
• Start date: January 2011
• Completion date: December 2015